{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:41:13Z","timestamp":1789425673462,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.cmi.2022.11.011","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T18:37:48Z","timestamp":1668883068000},"page":"537.e1-537.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Deciphering variable resistance to novel carbapenem-based \u03b2-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime\/avibactam"],"prefix":"10.1016","volume":"29","author":[{"given":"Vincenzo","family":"Di Pilato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Principe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Andriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Aiezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Coppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Giani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Luzzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Maria","family":"Rossolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2022.11.011_bib1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2022.11.011_bib2","unstructured":"European Centre for Disease Prevention and Control. Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae. 2018. Available at: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/rapid-risk-assessment-emergence-resistance-ceftazidime-avibactam-carbapenem"},{"key":"10.1016\/j.cmi.2022.11.011_bib3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(18)30605-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis","volume":"19","author":"Cassini","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2022.11.011_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2022.11.011_bib5","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-lactam-\u03b2-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2022.11.011_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/antibiotics11050628","article-title":"Resistance to ceftazidime\/avibactam, meropenem\/vaborbactam and imipenem\/relebactam in gram-negative MDR bacilli: molecular mechanisms and susceptibility testing","volume":"11","author":"Gaibani","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2022.11.011_bib7","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000028","article-title":"Outbreak of KPC-2-producing Klebsiella pneumoniae endowed with ceftazidime-avibactam resistance mediated through a VEB-1-mutant (VEB-25), Greece, September to October 2019","volume":"25","author":"Galani","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.cmi.2022.11.011_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhin.2022.02.001","article-title":"Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in a COVID-19 intensive care unit, Italy: urgent need for updated diagnostic protocols of surveillance cultures","volume":"122","author":"Bianco","year":"2022","journal-title":"J\u00a0Hosp Infect"},{"key":"10.1016\/j.cmi.2022.11.011_bib9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jgar.2021.04.001","article-title":"Resistance to ceftazidime\/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies","volume":"25","author":"Di Bella","year":"2021","journal-title":"J\u00a0Glob Antimicrob Resist"},{"key":"10.1016\/j.cmi.2022.11.011_bib10","unstructured":"International Organization for Standards. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices \u2014 Part 1: broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. 2019. Available at: https:\/\/www.iso.org\/standard\/70464.html"},{"key":"10.1016\/j.cmi.2022.11.011_bib11","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/S2666-5247(21)00268-8","article-title":"Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation","volume":"3","author":"Di Pilato","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.cmi.2022.11.011_bib12","doi-asserted-by":"crossref","first-page":"e01816","DOI":"10.1128\/AAC.01816-19","article-title":"Ceftazidime-avibactam resistance associated with increased blaKPC-3 gene copy number mediated by pKpQIL plasmid derivatives in sequence type 258 Klebsiella pneumoniae","volume":"64","author":"Coppi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib13","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/jac\/dkw227","article-title":"Characterization of KPC-encoding plasmids from two endemic settings, Greece and Italy","volume":"71","author":"Papagiannitsis","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib14","doi-asserted-by":"crossref","first-page":"5370","DOI":"10.1128\/AAC.05202-11","article-title":"Functional characterization of Tn4401, a Tn3-based transposon involved in blaKPC gene mobilization","volume":"55","author":"Cuzon","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib15","doi-asserted-by":"crossref","first-page":"e01429-20","DOI":"10.1128\/AAC.01429-20","article-title":"KPC-53, a KPC-3 variant of clinical origin associated with reduced susceptibility to ceftazidime-avibactam","volume":"65","author":"Di Pilato","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib16","doi-asserted-by":"crossref","first-page":"e01694","DOI":"10.1128\/AAC.01694-17","article-title":"Meropenem-vaborbactam resistance selection, resistance prevention, and molecular mechanisms in mutants of KPC-producing Klebsiella pneumoniae","volume":"61","author":"Sun","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010334","article-title":"Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniae","volume":"18","author":"David","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cmi.2022.11.011_bib18","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1080\/14656566.2019.1660772","article-title":"The latest advances in \u03b2-lactam\/\u03b2-lactamase inhibitor combinations for the treatment of gram-negative bacterial infections","volume":"20","author":"Papp-Wallace","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cmi.2022.11.011_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/14787210.2021.1935237","article-title":"Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies","volume":"20","author":"Karaiskos","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2022.11.011_bib20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1080\/14787210.2021.1924674","article-title":"Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel \u03b2-lactam-\u03b2-lactamase inhibitor combinations","volume":"19","author":"Galani","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2022.11.011_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.04.016","article-title":"Cross-resistance to cefiderocol and ceftazidime-avibactam in KPC \u03b2-lactamase mutants and the inoculum effect","volume":"27","author":"Hobson","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2022.11.011_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110227118","article-title":"Anatomy of an extensively drug-resistant Klebsiella pneumoniae outbreak in Tuscany, Italy","volume":"118","author":"Martin","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cmi.2022.11.011_bib23","doi-asserted-by":"crossref","first-page":"e01111","DOI":"10.1128\/AAC.01111-19","article-title":"Phenotypic, biochemical, and genetic analysis of KPC-41, a KPC-3 variant conferring resistance to ceftazidime-avibactam and exhibiting reduced carbapenemase activity","volume":"63","author":"Mueller","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00574-21","article-title":"Evolutionary trajectories toward ceftazidime-avibactam resistance in Klebsiella pneumoniae clinical isolates","volume":"65","author":"Carattoli","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib25","doi-asserted-by":"crossref","first-page":"e00989-17","DOI":"10.1128\/AAC.00989-17","article-title":"Resistance to ceftazidime-avibactam is due to transposition of KPC in a porin-deficient strain of Klebsiella pneumoniae with increased efflux activity","volume":"61","author":"Nelson","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00537-17","article-title":"Resistance to ceftazidime-avibactam in Klebsiella pneumoniae due to porin mutations and the increased expression of KPC-3","volume":"61","author":"Humphries","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14787210.2020.1756775","article-title":"Meropenem\/vaborbactam: a next generation \u03b2-lactam \u03b2-lactamase inhibitor combination","volume":"18","author":"Novelli","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.cmi.2022.11.011_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00256-22","article-title":"New perspectives on antimicrobial agents: imipenem-relebactam","volume":"66","author":"O\u2019Donnell","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2022.11.011_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00191-22","article-title":"Increased blaKPC copy number and OmpK35 and OmpK36 porins disruption mediated resistance to imipenem\/relebactam and meropenem\/vaborbactam in a KPC-producing Klebsiella pneumoniae clinical isolate","volume":"66","author":"Gaibani","year":"2022","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2200578X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2200578X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:35:35Z","timestamp":1761118535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2200578X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1198743X2200578X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2022.11.011","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering variable resistance to novel carbapenem-based \u03b2-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime\/avibactam","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2022.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}